Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
107% Returns: Tata's NBFC Doubles Investors Money, Rs 53,440 Profits On Rs 50K; Key Parameters To Buy/Sell -
KKR vs RR Memes: Fans Take Potshot at KKR for Conceding Match after Scoring 223; Praises Jos Buttler's Knock -
Dr Sarvepalli Radhakrishnan Death Anniversary: Profound And Inspiring Quotes For Students -
Bade Miyan Chote Miyan Vs Maidaan Box Office Collection Day 6: Akshay Kumar BEATS Ajay Devgn. Margin Is... -
UPSC Success Story: An IITian, A Government Job Holder at Railways, Quit the Job and Emerged as an IAS -
Jeep Compass Gets More Powerful 268.3bhp Turbo Petrol Engine – Check Out All The Details Here -
Redmi Pad SE With 90Hz Display Launching on April 23 in India; Could Be Priced for Less Than Rs 20,000 -
From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored
BioNTech, Pfizer ask Europe to OK vaccine for emergency use
Berlin, Dec 01: German pharmaceutical company BioNTech and its US partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency.
The two companies said on Tuesday that the submission, which occurred Monday, completes the rolling review process they initiated with the agency on October 6.
The move comes a day after rival Moderna said it was asking US and European regulators to allow emergency use of its COVID-19 vaccine.
Recommended Video
Farmer
Protest:
Farmers' meet
with
centre
ends,
no
decision
yet|Oneindia
News
BioNTech said that if the vaccine, currently named BNT162b2, is approved, its use in Europe could begin before the end of 2020.
Comments
